PLCD3 – Cardiovascular Disorder

The association between PLCD3 and cardiovascular disorder is primarily supported by genome‑wide association data that identified common variants in PLCD3 associated with blood pressure traits in large populations. In a landmark study of 34,433 European‐ancestry subjects with replication in an additional 71,225 European and 12,889 Indian Asian subjects (PMID:19430483), PLCD3 emerged as one of eight loci with variants significantly associated with both systolic and diastolic blood pressure. These findings connect the role of PLCD3 in blood pressure regulation—a key risk factor for cardiovascular disorder (MONDO_0004995). The statistical significance, with a reported p‑value of 1 × 10⁻⁸, underscores the reliability of the genetic association in a diverse set of cohorts. The large sample sizes provide robust support for the genetic association, although the common nature of the variant suggests a modest effect size.

In terms of genetic evidence, the multi‑patient study emphasizes that common variants in PLCD3 have a reproducible impact on blood pressure. The observed association provides a quantitative link between genetic variation and a clinical phenotype that is a well‐recognized risk factor for cardiovascular disease. While explicit familial segregation analysis was not performed in these genome‑wide studies, the broad replication across cohorts strengthens the genetic evidence. It is noteworthy that such common variant associations often rely on cumulative effects rather than rare high‐penetrance mutations. This paradigm is increasingly recognized in complex traits such as cardiovascular disorders.

A second large‑scale study evaluated phosphoinositide cycle gene polymorphisms in plasma lipid profiles among 680 subjects, but notably did not observe any association between PLCD3 polymorphisms and lipid parameters (PMID:19329342). Although the study focused on a related cardiovascular risk parameter, the negative findings in this context introduce a degree of complexity in interpreting the overall gene‑disease relationship. This contrast between blood pressure and lipid phenotype associations suggests that the contribution of PLCD3 to cardiovascular disorder may be pathway‑ and context‑specific.

The conflicting evidence highlights the necessity of integrating both positive and null findings. While the robust association with blood pressure measures is compelling, the null results from the lipid study imply that the pathogenic influence of PLCD3 may be limited to specific aspects of cardiovascular physiology. Consequently, the association is best understood in the context of polygenic risk rather than as a monogenic determinant of cardiovascular disease.

Functional evidence for PLCD3’s role in cardiovascular pathology is currently limited. Although experimental assessments in other contexts, such as studies examining PLCD3 in alopecia and cataract, have provided insights into the gene’s function, direct mechanistic studies linking PLCD3 to cardiovascular pathology are lacking. Without direct functional validation in cardiovascular models, the experimental support for this gene‑disease association remains modest. This gap in direct cardiovascular functional data tempers the overall confidence in the causal relationship while still complementing the genetic findings.

In conclusion, the integrated evidence suggests that PLCD3 is moderately associated with cardiovascular disorder via its influence on blood pressure regulation. The genetic evidence derived from extensive, multi‑cohort GWAS is robust, but the absence of direct functional studies in cardiovascular systems and conflicting findings in related phenotypes limit the overall clinical validity score. Key take‑home: PLCD3 contributes to the complex genetic architecture underlying cardiovascular risk and may serve as an adjunct marker in clinical decision‑making, warranting further research for translational applications.

References

• Nature genetics • 2009 • Genome-wide association study identifies eight loci associated with blood pressure PMID:19430483
• Molecular genetics and metabolism • 2009 • Phosphoinositide cycle gene polymorphisms affect the plasma lipid profile in the Quebec Family Study PMID:19329342

Evidence Based Scoring (AI generated)